Cite
HARVARD Citation
Hodsman, P. et al. (n.d.). A phase 1, randomized, placebo‐controlled, dose‐escalation study of an anti‐IL‐13 monoclonal antibody in healthy subjects and mild asthmatics. British journal of clinical pharmacology. pp. 118-128. [Online].